ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 255 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,652,958 | -24.6% | 247,598 | 0.0% | 2.45% | -10.6% |
| Q2 2023 | $8,829,345 | +40.4% | 247,598 | 0.0% | 2.74% | +34.0% |
| Q1 2023 | $6,288,989 | +62520.6% | 247,598 | 0.0% | 2.05% | -30.0% |
| Q4 2022 | $10,043 | -99.9% | 247,598 | 0.0% | 2.92% | +21.3% |
| Q3 2022 | $8,183,000 | -81.6% | 247,598 | -80.4% | 2.41% | -78.8% |
| Q2 2022 | $44,395,000 | -23.4% | 1,260,869 | 0.0% | 11.34% | +3.5% |
| Q1 2022 | $57,987,000 | -73.2% | 1,260,869 | -61.3% | 10.96% | -55.5% |
| Q4 2021 | $216,196,000 | +6.2% | 3,260,869 | 0.0% | 24.61% | +37.8% |
| Q3 2021 | $203,576,000 | – | 3,260,869 | – | 17.86% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Western Financial Corp/CA | 820,320 | $33,272,179 | 21.56% |
| Aquilo Capital Management, LLC | 1,103,515 | $44,758,568 | 16.81% |
| M28 Capital Management LP | 143,900 | $5,836,584 | 5.56% |
| WEALTH EFFECTS LLC | 155,620 | $6,311,951 | 3.60% |
| Evolutionary Tree Capital Management, LLC | 92,095 | $3,735,373 | 3.59% |
| Privium Fund Management B.V. | 221,015 | $8,867,122 | 3.36% |
| JOHNSON & JOHNSON | 247,598 | $10,043 | 2.92% |
| COMMODORE CAPITAL LP | 462,111 | $18,743 | 2.82% |
| Avidity Partners Management LP | 1,375,000 | $55,770,000 | 1.21% |
| Capital Impact Advisors, LLC | 26,853 | $1,089,158 | 1.06% |